The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer

作者
Rui Guo,Wanpu Yan,Fei Wang,Hua Su,Xiangxi Meng,Qing Mei Xie,Wei Zhao,Zhi Yang,Nan Li
出处
期刊:Cancer Imaging [BioMed Central]
卷期号:24 (1): 120-120 被引量:17
标识
DOI:10.1186/s40644-024-00772-x
摘要

Abstract Objective To evaluate the potential utility of 18 F-FDG PET/CT to assess response to neoadjuvant immunochemotherapy in patients with resectable NSCLC, and the ability to screen patients who may benefit from neoadjuvant immunochemotherapy. Methods Fifty one resectable NSCLC (stage IA–IIIB) patients were analyzed, who received two-three cycles neoadjuvant immunochemotherapy. 18 F-FDG PET/CT was carried out at baseline(scan-1) and prior to radical resection(scan-2). SULmax, SULpeak, MTV, TLG, T/N ratio, ΔSULmax%,ΔSULpeak%, ΔMTV%, ΔTLG%,ΔT/N ratio% were calculated. 18 F-FDG PET/CT responses were classified using PERCIST. We then compared the RECIST 1.1 and PERCIST criteria for response assessment.With surgical pathology of primary lesions as the gold standard, the correlation between metabolic parameters of 18 F-FDG PET/CT and major pathologic response (MPR) was analyzed. All metabolic parameters were compared to treatment response and correlated to PFS and OS. Results In total of fifty one patients, MPR was achieved in 25(49%, 25/51) patients after neoadjuvant therapy. The metabolic parameters of Scan-1 were not correlated with MPR.The degree of pathological regression was negatively correlated with SULmax, SULpeak, MTV, TLG, T/N ratio of scan-2, and the percentage changes of the ΔSULmax%, ΔSULpeak%, ΔMTV%,ΔTLG%,ΔT/N ratio% after neoadjuvant therapy ( p < 0.05). According to PERCIST, 36 patients (70.6%, 36/51) showed PMR, 12 patients(23.5%, 12/51) had stable metabolic disease(SMD), and 3 patients(5.9%, 3/51) had progressive metabolic disease (PMD). ROC indicated that all of scan-2 metabolic parameters and the percentage changes of metabolic parameters had ability to predict MPR and non-MPR, SULmax and T/N ratio of scan-2 had the best differentiation ability.The accuracy of RECIST 1.1 and PERCIST criteria were no statistical significance( p = 0.91). On univariate analysis, ΔMTV% has the highest correlation with PFS. Conclusions Metabolic response by 18 F-FDG PET/CT can predict MPR to neoadjuvant immunochemotherapy in resectable NSCLC. ΔMTV% was significantly correlated with PFS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
蝈蝈完成签到,获得积分10
刚刚
hbhsjk发布了新的文献求助10
刚刚
水煮电吹风的应助被刘之捷采纳,获得10
刚刚
刚刚
1秒前
小二郎的应助被youyyuy采纳,获得10
1秒前
zhouzhou完成签到,获得积分10
1秒前
上课呢完成签到 ,获得积分10
1秒前
psycancan完成签到 ,获得积分10
1秒前
2秒前
现代的向珊完成签到,获得积分20
2秒前
2秒前
2秒前
2秒前
456完成签到 ,获得积分10
3秒前
3秒前
Yiii完成签到,获得积分10
3秒前
3秒前
Ken发布了新的文献求助10
3秒前
4秒前
大胆鞯完成签到,获得积分10
4秒前
木木完成签到,获得积分10
5秒前
科研通AI6.3的应助被小胖采纳,获得10
5秒前
zmaifyc完成签到,获得积分10
5秒前
5秒前
Running完成签到 ,获得积分10
6秒前
傅敬业发布了新的文献求助10
6秒前
阿楠发布了新的文献求助10
6秒前
yanjia发布了新的文献求助150
6秒前
6秒前
sly完成签到,获得积分20
6秒前
6秒前
6秒前
322小弟发布了新的文献求助10
6秒前
7秒前
时尚的咖啡完成签到,获得积分10
7秒前
7秒前
魔法翼龙完成签到,获得积分10
7秒前
刘翰焜发布了新的文献求助10
7秒前
周周发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287